GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
19.60
-0.66 (-3.23%)
Apr 27, 2026, 4:00 PM EDT - Market closed
GH Research Employees
GH Research had 73 employees as of December 31, 2025. The number of employees increased by 23 or 46.00% compared to the previous year.
Employees
73
Change (1Y)
23
Growth (1Y)
46.00%
Revenue / Employee
n/a
Profits / Employee
-$661,068
Market Cap
1.22B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 73 | 23 | 46.00% |
| Dec 31, 2024 | 50 | 1 | 2.04% |
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| AbCellera Biologics | 562 |
| Wave Life Sciences | 317 |
| MapLight Therapeutics | 133 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
| ArriVent BioPharma | 77 |
| Savara | 70 |
GHRS News
- 7 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 7 days ago - Psychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug Research - Forbes
- 7 days ago - GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness - GlobeNewsWire
- 7 days ago - Psychedelic stocks rally with Trump's support - Market Watch
- 7 days ago - Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring. - Barrons
- 7 days ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters
- 4 weeks ago - GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD - GlobeNewsWire
- 7 weeks ago - GH Research Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire